Free shipping on all orders over $ 500

Clomifene citrate

Cat. No. M3564

All AbMole products are for research use only, cannot be used for human consumption.

Clomifene citrate Structure
Synonym:

Clomifene citrate

Size Price Availability Quantity
500mg USD 50  USD50 In stock
1g USD 60  USD60 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Clomifene citrate (Serophene) is a selective estrogen receptor modulator. Clomifene citrate (Serophene) increases production of gonadotropins by inhibiting negative feedback on the hypothalamus. Clomifene citrate (Serophene) is used mainly for ovarian stimulation in female infertility due to anovulation (e.g., infertility in polycystic ovary syndrome). Therapeutically, clomifene citrate (Serophene) is given early in the menstrual cycle. Clomifene citrate (Serophene) is typically prescribed beginning on day 1, 3 or 5 and continuing for 5 days. By that time, FSH level is rising steadily, causing development of a few follicles. Follicles in turn produce the estrogen, which circulates in serum. Clomifene acts by inhibiting the action of estrogen on the pituitary.

Chemical Information
Molecular Weight 598.08
Formula C26H28ClNO.C6H8O7
CAS Number 50-41-9
Solubility (25°C) DMSO 100 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Jingjing Jiang, et al. Therapeutic effects of dimethyldiguanide combined with clomifene citrate in the treatment of polycystic ovary syndrome

[2] Karen M Wheeler, et al. Clomiphene Citrate for the Treatment of Hypogonadism

[3] Nienke S Weiss, et al. Gonadotrophins versus clomifene citrate with or without intrauterine insemination in women with normogonadotropic anovulation and clomifene failure (M-OVIN): a randomised, two-by-two factorial trial

[4] Stefano Palomba, et al. Management strategies for ovulation induction in women with polycystic ovary syndrome and known clomifene citrate resistance

[5] S Bhattacharya, et al. Clomifene citrate or unstimulated intrauterine insemination compared with expectant management for unexplained infertility: pragmatic randomised controlled trial

Related Estrogen Receptor Products
GDC-0927

GDC-0927 (SRN-927) is a novel, potent, non-steroidal, orally bioavailable, selective estrogen receptor antagonist.

AC-186 

AC-186 is a selective non-steroidal estrogen receptor β (ERβ) agonist with EC50s of 6 nM and 5000 nM for ERβ and ERα, respectively.

Idoxifene

Idoxifene (CB7432) is a novel tissue-specific selective estrogen receptor modulator (SERM).

(R)-Equol

(R)-Equol is an agonist of both ERα and ERβ with Kis of 27.4 and 15.4 nM, respectively.

(Rac)-Vepdegestrant

(Rac)-Vepdegestrant is the isomer of Vepdegestrant.

  Catalog
Abmole Inhibitor Catalog




Keywords: Clomifene citrate, Clomifene citrate supplier, Estrogen Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.